Clinical Trials on Depression in Poland

Total 524 results

Rhode Island Hospital
National Institute of Mental Health (NIMH)

Completed

Text-Message-Based Depression Prevention for High-Risk Youth in the ED (iDOVE)

Depressive Disorder | Violence

United States
Forest Laboratories

Completed

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Depression | Bipolar Disorder

United States, Bulgaria, Poland, Puerto Rico, Lithuania, Estonia
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States, India, Puerto Rico
Forest Laboratories

Completed

Study of Escitalopram in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
AstraZeneca

Terminated

6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Pfizer

Completed

Study for Evaluating Different Methods of Measuring Depression Treatment Response

Depressive Disorder, Major

United States
Euthymics BioScience, Inc.

Completed

A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)

Major Depressive Disorder

United States
H. Lundbeck A/S

Completed

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

Depressive Disorder, Major

Spain, Hungary, Russian Federation, Bulgaria, Estonia, France, Germany, Italy, Latvia, Poland, Serbia, South Africa, United Kingdom
LivaNova

Recruiting

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER)

Treatment Resistant Depression

United States
Pfizer

Completed

Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

Major Depressive Disorder

Canada, United States, Colombia, Croatia, Estonia, Finland, Poland, France, Slovakia, Chile, Latvia, Lithuania, Romania, South Africa
Denovo Biopharma LLC

Completed

A Biomarker-Guided, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With Treatment-Resistant Depression (ENLIGHTEN)

Treatment Resistant Depression

United States, Canada
Axsome Therapeutics, Inc.

Completed

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder (STRIDE-1)

Treatment Resistant Major Depressive Disorder

United States
Eli Lilly and Company

Completed

A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder

Major Depressive Disorder

United States, South Africa, Poland, Ukraine, Japan, Russian Federation, Latvia
Sumitomo Pharma America, Inc.

Terminated

A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

Depressive Episodes, Bipolar I Depression

United States, Bulgaria, Japan
Brown University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Community-Based Integrated Treatment for Adolescents

Depression | Alcohol Use

United States
Otsuka Pharmaceutical Development & Commercialization...

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
Uppsala University

Completed

Internet Based Screening and Stepped Care for Cancer Patients With Anxiety and Depression Symptoms (AdultCan)

Depression | Cancer | Anxiety

Sweden
Shire

Completed

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Major Depressive Disorder

United States, Spain, Canada, Puerto Rico, Croatia, Mexico
Otsuka Pharmaceutical Development & Commercialization...

Completed

A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial

Mental Disorders | Depressive Disorder | Depression | Mood Disorders | Depressive Disorder, Major

United States, Poland, Serbia, Russian Federation, Germany, Canada, France
Alkermes, Inc.

Completed

A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

Major Depressive Disorder

United States, Bulgaria
Leiden University Medical Center

Recruiting

Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers (COXY)

Cannabis Use | Opioid Use | Respiratory Depression

Netherlands
Alkermes, Inc.

Completed

A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Canada
Eli Lilly and Company

Completed

A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

Major Depressive Disorder

Germany, United States, Puerto Rico, Sweden, Romania, France
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder

Depressive Disorder, Major

Finland, France, South Africa, Estonia, Croatia, Lithuania, Latvia, Slovakia, Poland, Romania
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder (MOONSTONE)

Major Depressive Disorder

United States
Shire

Completed

Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant

Major Depressive Disorder

United States
AstraZeneca

Completed

AZD7268 Safety and Tolerability Study

Major Depressive Disorder

United States
H. Lundbeck A/S

Completed

Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Irritability | Major Depressive Disorder

United States
Repligen Corporation

Completed

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

Bipolar I Depression

United States
Sunovion

Completed

Major Depressive Disorder With Mixed Features - Extension (RESOLVE3)

Major Depressive Disorder

United States
Sunovion

Completed

Lurasidone Pediatric Bipolar Study (Illuminate)

Bipolar I Depression

United States, Korea, Republic of, Bulgaria, Poland, Mexico, Puerto Rico, Colombia, Hungary, France, Philippines, Ukraine
AbbVie

Completed

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Canada, Czechia, Finland, Poland, Puerto Rico, Serbia, Slovakia
Wave Neuroscience

Completed

Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder

Depressive Disorder | Depression | Depressive Disorder, Major | Major Depressive Disorder | Depressive Episode

United States
DOV Pharmaceutical, Inc.

Terminated

Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder

Major Depressive Disorder

United States, Romania, Serbia
Assurex Health Inc.
University of Michigan

Completed

Genomics Used to Improve DEpression Decisions (GUIDED)

Major Depressive Disorder (MDD)

United States
Eli Lilly and Company

Completed

A Study in Relapse Prevention of Treatment-Resistant Depression

Treatment Resistant Depression

United States, Argentina, Russian Federation, South Africa, India, Turkey, Puerto Rico, Mexico
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Depressive Disorder, Major

United States
Forest Laboratories

Completed

Safety Study of F2695 SR in Major Depressive Disorder (LVM-MD-04)

Major Depressive Disorder

United States
ACADIA Pharmaceuticals Inc.

Terminated

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Adjunctive Treatment of Major Depressive Disorder

United States, Serbia, Finland, Poland, Russian Federation, Slovakia, South Africa, Ukraine, United Kingdom
Genaissance Pharmaceuticals

Completed

Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response

Depressive Disorder, Major

United States
Universitat Jaume I
Research Unit in Primary Care of Aragon (Spain)

Unknown

Effectiveness of a Brief Psychological Mindfulness Based Intervention for the Treatment of Depression in Primary Care

Depressive Disorder

Spain
Sunovion

Completed

A Safety, Efficacy and Tolerability Study of SEP-225289

Depressive Disorder, Major

United States
Neuralstem Inc.

Unknown

A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Neurocrine Biosciences

Completed

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD) (SAVITRI)

Major Depressive Disorder

United States, Czechia, Bulgaria, Poland, Slovakia, Sweden
University School of Physical Education in Wroclaw
Foundation for Senior Citizen Activation SIWY DYM

Completed

Virtual Therapy as a Method Supporting the Cardiac Rehabilitation

Cardiovascular Diseases | Coronary Artery Disease | Mood Disorders | Stress | Depressive Symptoms | Anxiety State

Poland
VU University of Amsterdam
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Rumination-focused CBT Training for the Prevention of Depression and Anxiety

Depression | Anxiety Disorders

Netherlands
US Department of Veterans Affairs

Completed

Genetic and Biochemical Markers of Interferon-Induced Depression.

Depression

United States
Wave Neuroscience

Completed

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder (NEST-MDD)

Major Depressive Disorder

United States
Axsome Therapeutics, Inc.

Completed

A Trial of AXS-05 in Patients With Major Depressive Disorder (GEMINI)

Depression | Major Depressive Disorder

United States

Clinical Trials on Depression in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations